Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2026-05-27 15:24:20 ET · period of report 2026-05-26 · accession 0001649989-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 15:24 | 2026-05-26 | OTLK | Haddadin Yezan Munther | Dir | P - Purchase | $0.44 | +34.0K | 37.2K | +1,074% | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-26 | P | A | 34,000 | $0.44 | 37,167 | D | — | — |